Cyclin B1 peptide-pulsed autologous dendritic cell vaccine

Cyclin B1 peptide-pulsed autologous dendritic cell vaccine · Milton S. Hershey Medical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cyclin B1 peptide-pulsed autologous dendritic cell vaccine, covering 2017-08-22 to 2017-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer [NA]

See pricing